See what the IHS Markit Score report has to say about ResMed Inc. Mon, 20 Nov 2017 13:08:07 +0000 Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on October 31. Index (PMI) data, output in the Healthcare sector is rising.
3 Top Medical Device Stocks to Buy Now Sat, 18 Nov 2017 16:32:00 +0000 Looking to put money to work in this under-the-radar sector? Here are three top stocks to consider.
ETFs with exposure to ResMed, Inc. : November 13, 2017 Mon, 13 Nov 2017 18:07:13 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ResMed, Inc. Here are 5 ETFs with the largest exposure to RMD-US. Comparing the performance and risk of ResMed, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Statement by ResMed on United Kingdom Case with Fisher & Paykel Mon, 13 Nov 2017 01:51:00 +0000 SAN DIEGO , Nov. 13, 2017 /PRNewswire/ -- ResMed (NYSE: RMD, ASX: RMD) today issued the following statement from David Pendarvis , the company's global general counsel and chief administrative officer: ...
Fisher & Paykel says UK court rules rival Resmed's patent is invalid Sun, 12 Nov 2017 22:16:16 +0000 New Zealand's Fisher & Paykel Healthcare (FPH.NZ) said on Monday that it could continue to sell its sleep apnea masks in Britain as a UK court had ruled that rival Resmed Inc's (RMD.N) patent was invalid. Fisher & Paykel filed the case against California-based Resmed in Britain's High Court in 2016, and has similar legal proceedings underway in Germany, after Resmed had said the New Zealand company's masks violated Resmed patents. "This result confirms that UK patients can continue to purchase and enjoy the benefits of our high-performance masks," Fisher & Paykel said in a statement in which it announced the UK court ruling.
SleepScore Labs Launches the World's Most Advanced Sleep Improvement System Fri, 10 Nov 2017 14:00:00 +0000 CARLSBAD, Calif., Nov. 10, 2017 /PRNewswire/ -- SleepScore Labs, the company behind the most advanced non-contact sleep improvement systems for consumers, announced today the availability of its newest non-contact device, SleepScore Max. SleepScore Max, available for purchase at www.sleepscore.com, is the world's most accurate and sophisticated sleep improvement system. Small and attractive enough to sit on a nightstand, the device calculates a nightly SleepScore (between 0–100) based on an individual's quality and quantity of sleep – without the need for a wearable tracker or bed strip beneath the mattress.
Read This Before Buying ResMed Inc (RMD) For Its Upcoming $0.35 Dividend Sat, 04 Nov 2017 00:49:27 +0000 Important news for shareholders and potential investors in ResMed Inc (NYSE:RMD): The dividend payment of $0.35 per share will be distributed into shareholder on 14 December 2017, and the stockRead More...
ResMed, Inc. :RMD-US: Earnings Analysis: Q1, 2018 By the Numbers : November 1, 2017 Wed, 01 Nov 2017 13:34:16 +0000 Categories: Yahoo FinanceGet free summary analysis ResMed, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ResMed, Inc. – Thermo Fisher Scientific Inc. (TMO-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 523.66 million, Net Earnings of USD 86.13 million. ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.